Skip to main content
. 2017 Jan 20;49(1):e286. doi: 10.1038/emm.2016.131

Table 2. FOXO3a-based characterization of parental cell lines and their proliferative response to glucose-modified PacR cancer cell secretome.

      +Glucose (+25 mM glucose)
−Glucose (glucose-deprived)
      Cell proliferation (%±s.d., 48 h rel. 24 h)
Cell proliferation (%±s.d., 48 h rel. 24 h)
      Fresh medium PacR secretome
  PacR secretome
Phenotype description Cell line ID FOXO3a WB grade   siControl siFOXO3a Fresh medium siControl siFOXO3a
Parent A549 a 60.1±0.6 58.5±2.1 42.1±1.4 28.1±4.2 29.4±4.2 9.3±6.8
Paclitaxel resistance (PacR) A549-PacR b 83±1.67 79.3±3.9 58.1±2.2 33.0±3.3 30.8±2.1 12.1±2.1
Transient cross-resistant PacR A549-PacR/DCT b 112.3±0.5 110.2±0.3 85.8±7.1 41.0±0.9 37.7±1.6 18.6±3.2
Parent PC-3 a 54.2±1.2 51.3±1.3 31.3±8.2 22.1±1.8 20.1±2.9 10.2±1.1
Paclitaxel resistance (PacR) PC-3-PacR b 69.1±0.4 66.5±1.5 29.6±3.3 31.2±1.7 29.1±2.2 15.9±0.8
Transient cross-resistant PacR PC-3-PacR/DCT c 89.7±2.2 82.1±2.1 54.4±5.2 29.2±3.2 31.3±0.5 15.2±2.1

Abbreviation: WB, western blot.

a

Low level expression.

b

Medium level expression.

c

rel., relative to.